BeStock  
Stocks › Biotechnology › EXEL

Exelixis EXEL

US equityMarket cap rank #1070Biotechnology
$64.63 −$1.20 (-1.82%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $64.63 0.00%
Open$65.95
Prev close$65.83
Day range$64.45 – $66.94
Volume2.19M
Market cap$15.77B
P/E (TTM)19.4
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership103.2%+0.16 pts vs. prior quarter
Institutions holding918-5 vs. prior quarter
Insider trades (recent)17 buys / 33 sellsNet selling
Short interest10.49% of floatDays to cover 11.7 · as of 30 Oct 2026
Short-sale volume share21.0%5-day average of daily volume

Short-sale volume as % of daily volume

7%14%21%28%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$14.65M (10 inflow days, 10 outflow days).

Net flow by order size, last 20 sessions

−$8.8MSuper−$5.8MBig−$1.7MMid−$2.1MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 33.4% of shares outstanding.

Largest holders

  • BlackRock12.19%
  • Farallon Capital Management, L.L.C.6.02%
  • Renaissance Technologies Corp.5.24%
  • Vanguard Capital Management, LLC5.05%
  • Vanguard Portfolio Management, LLC4.90%
  • State Street Global Advisors4.31%
  • AQR Capital Management3.90%
  • Fuller & Thaler Asset Management, Inc.3.60%

By investor type

  • Mutual Fund70.83%
  • Hedge Fund22.10%
  • Public Company4.55%
  • Individual/Insider2.67%
  • Government Pension Fund2.28%
  • Private Company1.20%
  • Sovereign Wealth Fund1.10%
  • Insurance Company0.50%

Reported short interest has fallen from 11.31% to 10.49% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Morgan Stanley Public Company 2026/Q4 +1,782,452 1.8%
Deka Investment GmbH Mutual Fund 2026/Q4 +922,747 0.6%
Jupiter Fund Management Plc Mutual Fund 2026/Q4 +858,641 0.4%
BlackRock Mutual Fund 2026/Q4 +668,074 12.2%
American Century Investment Management Mutual Fund 2026/Q4 +601,002 1.0%
Geode Capital Management, LLC Mutual Fund 2026/Q4 +592,231 3.4%
State Street Global Advisors Mutual Fund 2026/Q4 +551,416 4.3%
Acadian Asset Management LLC Mutual Fund 2026/Q4 +544,626 0.4%
Allspring Global Investments, LLC Mutual Fund 2026/Q4 +429,505 1.0%
Invesco Capital Management LLC Mutual Fund 2026/Q4 +393,503 1.7%
First Trust Advisors L.P. Mutual Fund 2026/Q4 +277,694 1.2%
LPL Financial LLC Mutual Fund 2026/Q4 +252,844 0.2%
The Norden Group LLC Mutual Fund 2026/Q4 +234,825 0.1%
Merit Financial Group, LLC Mutual Fund 2026/Q4 +232,071 0.1%
Raymond James Financial, Inc. Public Company 2026/Q4 +231,187 0.5%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
9 Aug 2026 Mary Beckerle Independent Director Automatic Disposition -9,812 $53.66 –
31 May 2026 Jack Wyszomierski Independent Director Automatic Disposition -3,925 $50.55 284,384
31 May 2026 Sue Eckhardt Independent Director Automatic Disposition -9,812 $50.14 16,079
26 May 2026 Jack Wyszomierski Independent Director Other Acquisition +8,367 – 8,367
26 May 2026 Stelios Papadopoulos Co-Founder & Independent Chair of the Board Other Acquisition +8,367 – 8,367
26 May 2026 George Poste Independent Director Other Acquisition +8,367 – 8,367
26 May 2026 Sue Eckhardt Independent Director Other Acquisition +8,367 – 16,079
26 May 2026 Mary Beckerle Independent Director Other Acquisition +8,367 – 16,079
26 May 2026 Julie Smith Independent Director Other Acquisition +8,367 – 8,367
26 May 2026 Maria Freire Independent Director Other Acquisition +8,367 – 8,367
26 May 2026 Robert Oliver Independent Director Other Acquisition +8,367 – 17,455
26 May 2026 Tomas Heyman Independent Director Other Acquisition +8,367 – 17,455
26 May 2026 David Johnson Independent Director Other Derivative Acquisition +19,133 $50.03 19,133
25 May 2026 Dana Aftab Officer Intent to Sell (Form 144) -43,451 $50.35 –
19 May 2026 Patrick Haley Executive Vice President of Commercial Open Market Disposition -32,110 $49.81 357,638
17 May 2026 Michael Morrissey Chief Executive Officer Other Acquisition +124,047 – 3,384,063
17 May 2026 Michael Morrissey Chief Executive Officer Other Disposition -124,047 – 3,384,063
17 May 2026 Christopher Senner Chief Financial Officer Open Market Disposition -34,901 $50.00 551,125
17 May 2026 Brenda Hefti General Counsel Automatic Disposition -6,625 $50.21 6,250
14 May 2026 Michael Morrissey Chief Executive Officer Sale to Issuer -128,497 $51.10 3,384,063

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 25,593,708 10.5% 11.7
15 Oct 2026 27,313,139 11.0% 11.3
30 Sep 2026 28,183,726 11.4% 12.7
15 Sep 2026 26,400,456 10.7% 12.4
31 Aug 2026 28,656,285 11.6% 14.9
14 Aug 2026 28,031,459 11.3% 8.7

Discussion

No comments yet — be the first to weigh in on EXEL.

Sign in to join the discussion.

Scroll to Top